Crispr Therapeutics is an emerging gene editing company focused on the development of Crispr/Cas9-based therapeutics. The company's proprietary platform specializes in clustered regularly interspaced ...

Thalassemia and sickle cell anaemia are common genetic disorders in India. Early testing, prenatal screening, and improved ...

Norah Awad has lived with beta thalassemia major, a severe blood disorder that has required monthly transfusions since she ...

One specialist argued that, in the future, gene therapy technologies will be the favored option for wet AMD. Another emphasized that there are still challenges and limitations that need to be ...

Thalassemia and Sickle Cell Anaemia are the commonest single-gene disorders globally ... The expected annual births of beta thalassemia major babies were also calculated for each district in ...

Also Read: Gene Edit Biotech Beam Therapeutics Touts Encouraging Data From Early-Stage Gene Therapy Study In Genetic Disorder, Raises $500 Million Via Equity Initial safety and efficacy data from ...

5 of 6 patients showed >10% LVMI improvement in 12 months; 27% mean LVMI gain was seen at the latest visit. 11 of 12 participants saw an over 25% drop in troponin I and a 115% average frataxin ...

Atsena, a clinical-stage biotech company, launched in 2020 with a mission to use gene therapy to reverse or prevent blindness in inherited retinal diseases. It plans to use proceeds from the Series C ...

The feature is currently being tested in the latest WhatsApp beta for Android, version 2.25.10.14, available on the Google Play Store, according to a report by WABetaInfo. The upcoming privacy ...

The clinical characteristics of 152 children under the age of 15 with severe beta-thalassemia ... analysis in this paper is a major defect of this study. The incidence of hemorrhagic cystitis (HC) in ...